Two possible pathways for acquisition of mutations related to nelfinavir resistance

Jpn J Infect Dis. 1999 Aug;52(4):175-6.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Drug Resistance, Microbial / genetics*
  • HIV Infections / drug therapy
  • HIV Protease Inhibitors / therapeutic use*
  • Humans
  • Mutation*
  • Nelfinavir / therapeutic use*
  • Ritonavir / therapeutic use
  • Saquinavir / therapeutic use

Substances

  • HIV Protease Inhibitors
  • Nelfinavir
  • Saquinavir
  • Ritonavir